Professor Paul Workman pledges three-pronged attack on cancer evolution and drug resistance
21 November 2014 | By The Institute of Cancer Research
Professor Paul Workman sets out his vision for cancer drug discovery as he is appointed Chief Executive of The Institute of Cancer Research, London